All News #Library
Rare Diseases
Marinus Pharmaceuticals Announces Results From TrustTSC Trial
24 Oct 2024 //
BUSINESSWIRE
Marinus Announces Updates For Tuberous Sclerosis Program
17 May 2024 //
BUSINESSWIRE
Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone
22 Mar 2023 //
BUSINESSWIRE

Market Place
Sourcing Support